Home
Location: United States, Massachusetts, Cambridge
Founded date: 2016
Investors 4
| Date | Name | Website |
| 21.04.2023 | Plug and P... | plugandpla... |
| 17.11.2020 | DigiTx Par... | digitxpart... |
| - | R/GA Ventu... | ventures.r... |
| - | XLerateHea... | xleratehea... |
Mentions in press and media 10
| Date | Title | Description |
| 26.12.2022 | The way you type is the key to living a better life - nQ Medical / Fleksy partnership | nQ Medical will leverage its FDA clearance to deliver the nQ/Fleksy keyboard to hundreds of thousands of PwND through its Virtual First Neurology Care Solution, called NeuroCare. CAMBRIDGE, Mass., Dec. 26, 2022 /PRNewswire-PRWeb/ -- The wor... |
| 26.12.2022 | The way you type is the key to living a better life - nQ Medical / Fleksy partnership | Digital health holds enormous potential for improving clinical care of people with neurological disorders CAMBRIDGE, Mass. (PRWEB) December 26, 2022 The world has rapidly evolved in the past decade. Most recently, it has been progressing at... |
| 22.12.2022 | AI Trends For 2023: Industry Experts (And ChatGPT AI) Make Their Predictions | Top 2023 AI Predictionsgetty |
| 09.08.2022 | nQ’s Study of Digital Biomarkers for Subdomain Analysis of Cognition Published in Brain Communications | CAMBRIDGE, Mass. (PRWEB) August 09, 2022 People’s keystroke patterns generated from their daily interaction with computers and smartphones can reveal important information about their cognitive state, according to new research published by ... |
| 31.01.2022 | The Future Of Medicine: Fighting Deadly Diseases With Smart Devices And Digital Biomarkers | How the future of healthcare is shaped by passive data and intelligent algorithms getty |
| 15.04.2021 | nQ Medical, a Digital Biomarker Discovery Platform, Unveils Latest COBRE Clinical Trial Results in Cognitive Impairment Across the AD Spectrum at AAN 2021 Annual Meeting | nQ Medical's results, Alzheimer’s Disease Spectrum COBRE TRIAL at Cleveland Clinic Lou Ruvo Center for Brain Health Dr. Miller, Dir of Neuropsychology, Cleveland Clinic Lou Ruvo Center for Brain Health, quoted Leurent and Ehlers, concluding... |
| 11.03.2021 | nQ Medical, a Digital Biomarker Discovery Platform, Unveils Latest Alzheimer’s Disease Clinical Trial Results at AD/PD 2021 International Conference | nQ Medical's results, Alzheimer’s Disease study at Cleveland Clinic Lou Ruvo Center for Brain Health nQ’s novel technology uses machine learning to capture and analyze an individual’s typing performance on keyboard or smartphone. Data is ca... |
| 23.12.2019 | MIT Technology Review presents the Innovators Under 35 Europe 2019 | Since 1999, MIT Technology Review recognizes the young innovators and most talented entrepreneurs from different countries who are developing new technologies to help solve the problems that affect our society nowadays. These young bright m... |
| - | Siris Medical Inc. Raises $4 Million to Improve Cancer Radiation Treatment With Artificial Intelligence | DigiTx Partners Leads Series A1 Round with Participation from Medical Technology Venture Partners September 19, 2017 12:09 PM Eastern Daylight Time SAN FRANCISCO--Siris Medical, a Redwood City-based company which has commercialized the fi... |
| - | FDA Grants Breakthrough Device Designation to nQ Medical for Parkinson’s Disease Management Platform | WASHINGTON (PRWEB) FEBRUARY 06, 2020 The U.S. Food and Drug Administration (FDA) has granted “Breakthrough Device” designation to nQ Medical for its neuroQWERTY brain health monitoring solution. The designation is granted for “The neuroQ... |